Innovator IBD 50 ETF Rating $37.31 -0.39 (-1.03%) As of 07/24/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Innovator IBD 50 ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FFTY Aggregate RatingModerate Buy 2.80Holdings in FFTY have an aggregate rating of Moderate Buy based on 403 analyst ratings issued in the past year covering 25 companies (74.3% of the portfolio).FFTY Aggregate Price Target$37.31High Prediction$37.31Average Prediction$37.31Low Prediction$37.31Holdings in FFTY have an aggregate price target of $37.31 and a range of $37.31 to $37.31 covering 25 companies (74.3% of the portfolio).FFTY Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Innovator IBD 50 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FFTY Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.66%DAVEDave$402.81-1.4%3.4617 of 5 stars3.00$379.40 -5.8%13Trending News3.54%ASTHAstrana Health$40.31-1.7%3.963 of 5 stars2.78$47.86 18.7%93.51%AMDAdvanced Micro Devices$521.95-3.3%3.004 of 5 stars2.75$522.43 0.1%44Trending NewsAnalyst Forecast3.50%AXSMAxsome Therapeutics$241.00-0.2%2.7174 of 5 stars2.91$261.48 8.5%23Positive News3.48%TGTXTG Therapeutics$56.04+1.0%2.5457 of 5 stars2.56$53.33 -4.8%9Positive News3.44%TVTXTravere Therapeutics$57.36+1.2%1.9176 of 5 stars2.69$52.08 -9.2%13News CoveragePositive News3.44%LQDALiquidia$86.22-3.2%3.3131 of 5 stars2.82$86.18 0.0%11Analyst ForecastOptions VolumeAnalyst Revision3.42%CRSCarpenter Technology$603.70+0.4%3.7921 of 5 stars3.00$556.75 -7.8%10Positive NewsUpcoming Earnings3.26%MUMicron Technology$920.95-7.0%4.8812 of 5 stars3.03$1,268.93 37.8%37Trending NewsGap Down3.26%PTRNPattern Group$22.17-5.6%2.628 of 5 stars2.67$22.89 3.2%12News Coverage3.09%GHGuardant Health$147.33-1.9%3.1621 of 5 stars2.96$160.04 8.6%25News CoveragePositive NewsUpcoming Earnings3.02%HNGEHinge Health$74.21-3.2%4.1584 of 5 stars2.95$84.27 13.6%19Analyst Forecast3.00%LRCXLam Research$305.21-4.6%4.8831 of 5 stars2.88$360.51 18.1%34Trending NewsUpcoming EarningsAnalyst UpgradeGap Down2.95%ALABAstera Labs$291.58-10.8%3.2619 of 5 stars2.52$282.00 -3.3%23Positive NewsGap Down2.93%KNSAKiniksa Pharmaceuticals International$62.84-0.3%2.8989 of 5 stars3.00$68.00 8.2%9News CoverageUpcoming EarningsAnalyst Forecast2.92%CRDOCredo Technology Group$213.15-9.9%4.575 of 5 stars3.00$266.17 24.9%19Positive NewsAnalyst ForecastGap Down2.91%OSCROscar Health$28.16-2.6%2.2518 of 5 stars2.33$20.78 -26.2%12News Coverage2.84%MIRMMirum Pharmaceuticals$113.03-1.2%2.8937 of 5 stars2.93$143.40 26.9%15Upcoming Earnings2.83%KRYSKrystal Biotech$335.19+2.3%3.1382 of 5 stars2.83$360.67 7.6%12News CoveragePositive News2.52%OUSTOuster$34.04-9.7%3.8763 of 5 stars2.56$54.67 60.6%9Analyst Forecast2.24%SEZLSezzle$153.89-3.2%2.8088 of 5 stars2.56$151.33 -1.7%92.23%WTWisdomTree$19.42-1.4%2.7592 of 5 stars2.71$20.06 3.3%7News CoverageUpcoming Earnings2.17%ENVAEnova International$237.13+8.9%3.9061 of 5 stars2.89$247.83 4.5%9Trending NewsEarnings ReportAnalyst ForecastGap UpHigh Trading Volume2.08%RSIRush Street Interactive$31.41+0.3%3.2104 of 5 stars2.85$33.11 5.4%13Upcoming EarningsAnalyst Forecast2.06%INDVIndivior$40.53+0.0%2.1318 of 5 stars2.71$43.67 7.7%7News CoverageUpcoming Earnings This page (NYSEARCA:FFTY) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | SponsoredWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD 50 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD 50 ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FFTY Stock Alerts